ArticleInternational journal of health policy and management2017
Health Technology Assessment: Global Advocacy and Local Realities Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness".
Article in International journal of health policy and management, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Community participation and stakeholder engagement in determining health service coverage: A systematic review and framework synthesis to assess effectiveness.Journal of global health · 2023Pooled it
- Strengthening country ownership of national antimalarial policymaking: insights from Laos, Pakistan and the Solomon Islands.Malaria journal · 2025Article
- The potential impact of declining development assistance for health on population health in Malawi: A modelling study.PLoS medicine · 2025Article
- The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making.BMC medicine · 2023Article
- Factors influencing institutionalization of health technology assessment in Kenya.BMC health services research · 2023Article
- Organising Research and Development for evidence-informed health care: some universal characteristics and a case study from the UK.Health economics, policy, and law · 2021Review
- Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis.Cost effectiveness and resource allocation : C/E · 2021Article
- Health technology assessment and judicial deference to priority-setting decisions in healthcare: Quasi-experimental analysis of right-to-health litigation in Brazil.Social science & medicine (1982) · 2020Article
- Health technology assessment: a framework.RMD open · 2020Article
- Accelerating access to medicines in a changing world.Bulletin of the World Health Organization · 2020Article
- Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.International journal of health policy and management · 2020Article
- What next after GDP-based cost-effectiveness thresholds?Gates open research · 2020Article
- Expanding HTA - Correcting a Misattribution, Clarifying the Scope of HTA and CEA Comment on "Ethics in HTA: Examining the 'Need for Expansion'".International journal of health policy and management · 2019Article
- Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice Comment on "Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy".International journal of health policy and management · 2019Article
- Addressing the information deficit in global health: lessons from a digital acute care platform in Sri Lanka.BMJ global health · 2019Article
- Decisions of Value: Going Backstage Comment on "Contextual Factors Influencing Cost and Quality Decisions in Health and Care: A Structured Evidence Review and Narrative Synthesis".International journal of health policy and management · 2018Article
- Article
- Evidence-Informed Deliberative Processes - Early Dialogue, Broad Focus and Relevance: A Response to Recent Commentaries.International journal of health policy and management · 2018Article
- Strengthening health technology assessment systems in the global south: a comparative analysis of the HTA journeys of China, India and South Africa.Global health action · 2018Article
- We need a NICE for global development spending.F1000Research · 2017Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cost-effectiveness analysis (CEA) can help countries attain and sustain universal health coverage (UHC), as long as it is context-specific and considered within deliberative processes at the country level. Institutionalising robust deliberative processes requires significant time and resources, however, and countries often begin by demanding evidence (including local CEA evidence as well as evidence about local values), whilst striving to strengthen the governance structures and technical capacities with which to generate, consider and act on such evidence. In low- and middle-income countries (LMICs), such capacities could be developed initially around a small technical unit in the health ministry or health insurer. The role of networks, development partners, and global norm setting organisations is crucial in supporting the necessary capacities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.